| Reference |
|---|
Esen M, Fischer Herr J, Gabor J, Gaile J, Fleischmann W, Smeenk G, et al. First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster. Vaccines (Basel). 2024;12: pubmed publisher |
Verbrugghe C, Wouters E, Devloo R, Nurmi V, Seghers S, De Bleser D, et al. Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma. Sci Rep. 2024;14:23579 pubmed publisher |
Ou B, Baillet J, Filsinger Interrante M, Adamska J, Zhou X, Saouaf O, et al. Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses. Sci Adv. 2024;10:eadn7187 pubmed publisher |
Poulakou G, Royer P, Evgeniev N, Evanno G, Shneiker F, Marcelin A, et al. Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19. Front Immunol. 2024;15:1330178 pubmed publisher |
Jansen E, Ostadgavahi A, Hewins B, Buchanan R, Thivierge B, Sganzerla Martinez G, et al. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females. Sci Rep. 2024;14:9854 pubmed publisher |
Kinoshita M, Muranishi K, Kawaguchi K, Sudo K, Inoue K, Ishikura H, et al. Immunological Response to Subcutaneous and Intranasal Administration of SARS-CoV-2 Spike Protein in Mice. Vaccines (Basel). 2024;12: pubmed publisher |
Maji D, Miguela V, Cameron A, Campbell D, Sasset L, Yao X, et al. Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies. Pharmaceutics. 2024;16: pubmed publisher |
Park S, Choi J, Lee Y, Noh J, Kim N, Lee J, et al. An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation. Nat Commun. 2024;15:3368 pubmed publisher |
Guo Y, Wu S, Li W, Yang H, Shi T, Ju B, et al. The cryo-EM structure of homotetrameric attachment glycoprotein from langya henipavirus. Nat Commun. 2024;15:812 pubmed publisher |
Khan I, Li S, Tao L, Wang C, Ye B, Li H, et al. Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1. Nat Commun. 2024;15:162 pubmed publisher |
Heo C, Lim W, Yang J, Son S, Kim S, Kim D, et al. Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern. Front Immunol. 2023;14:1307693 pubmed publisher |
Chiuppesi F, Ortega Francisco S, Gutiérrez M, Li J, Ly M, Faircloth K, et al. Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy. Vaccines (Basel). 2023;11: pubmed publisher |
Stewart Jones G, Elbashir S, Wu K, Lee D, Renzi I, Ying B, et al. Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2. Sci Transl Med. 2023;15:eadf4100 pubmed publisher |
Ou B, Baillet J, Filsinger Interrante M, Adamska J, Zhou X, Saouaf O, et al. Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Improve Vaccine Immunomodulation. bioRxiv. 2023;: pubmed publisher |
Mulgaonkar N, Wang H, Zhang J, Roundy C, Tang W, Chaki S, et al. Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant. Pharmaceutics. 2023;15: pubmed publisher |
Tong X, McNamara R, Avenda xf1 o M, Serrano E, Garc xed a Salum T, Pardo Roa C, et al. Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination. Nat Commun. 2023;14:4174 pubmed publisher |
Hunt A, V xf6 geli B, Hassan A, Guerrero L, Kightlinger W, Yoesep D, et al. A rapid cell-free expression and screening platform for antibody discovery. Nat Commun. 2023;14:3897 pubmed publisher |
Chen X, Lin Y, Yue S, Yang Y, Yang X, He J, et al. PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness. Vaccine. 2023;41:4986-4995 pubmed publisher |
Han X, Alameh M, Butowska K, Knox J, Lundgreen K, Ghattas M, et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat Nanotechnol. 2023;: pubmed publisher |
Tai W, Feng S, Chai B, Lu S, Zhao G, Chen D, et al. An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants. Nat Commun. 2023;14:2962 pubmed publisher |
Wouters E, Verbrugghe C, Abdelnabi R, Devloo R, De Clippel D, Jochmans D, et al. Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters. EBioMedicine. 2023;92:104597 pubmed publisher |
Adams L, Leist S, Dinnon K, West A, Gully K, Anderson E, et al. Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination. Cell Rep. 2023;42:112326 pubmed publisher |
Park K, Choi A, Kim H, Park I, Eom M, Yeo S, et al. Ultra-sensitive label-free SERS biosensor with high-throughput screened DNA aptamer for universal detection of SARS-CoV-2 variants from clinical samples. Biosens Bioelectron. 2023;228:115202 pubmed publisher |
Emmenegger M, Worth R, Fiedler S, Devenish S, Knowles T, Aguzzi A. Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling. STAR Protoc. 2023;4:102095 pubmed publisher |
Wu K, Chugh V, D Krishna V, Wang Y, Gordon T, Cheeran M, et al. Five-Minute Magnetic Nanoparticle Spectroscopy-Based Bioassay for Ultrafast Detection of SARS-CoV-2 Spike Protein. ACS Appl Nano Mater. 2022;5:17503-17507 pubmed publisher |
Langel S, Garrido C, Phan C, Travieso T, Kirshner H, DeMarco T, et al. Dam-Infant Rhesus Macaque Pairs to Dissect Age-Dependent Responses to SARS-CoV-2 Infection. Immunohorizons. 2022;6:851-863 pubmed publisher |
Wu J, Chen L, Qin C, Huo F, Liang X, Yang X, et al. CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis. Signal Transduct Target Ther. 2022;7:382 pubmed publisher |
Song J, Chow R, Pe xf1 a Hern xe1 ndez M, Zhang L, Loeb S, So E, et al. LRRC15 inhibits SARS-CoV-2 cellular entry in trans. PLoS Biol. 2022;20:e3001805 pubmed publisher |
Lu J, Wang Y, Yang M, Wang C, Meng J, Liu J, et al. Structures, biomimetic synthesis, and anti-SARS-CoV-2 activity of two pairs of enantiomeric phenylpropanoid-conjugated protoberberine alkaloids from the rhizomes of Corydalis decumbens. Arch Pharm Res. 2022;45:631-643 pubmed publisher |
Hawman D, Meade White K, Clancy C, Archer J, Hinkley T, Leventhal S, et al. Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine. EBioMedicine. 2022;83:104196 pubmed publisher |
Besselink G, Sch xfc tz Trilling A, Veerbeek J, Verbruggen M, van der Meer A, Schonenberg R, et al. Asymmetric Mach-Zehnder Interferometric Biosensing for Quantitative and Sensitive Multiplex Detection of Anti-SARS-CoV-2 Antibodies in Human Plasma. Biosensors (Basel). 2022;12: pubmed publisher |
Emmenegger M, Fiedler S, Brugger S, Devenish S, Morgunov A, Ilsley A, et al. Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants. iScience. 2022;25:104766 pubmed publisher |
Wu F, Luo S, Zhang Y. Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity. Acta Pharm Sin B. 2022;: pubmed publisher |
Chiuppesi F, Zaia J, Faircloth K, Johnson D, Ly M, Karpinski V, et al. Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants. iScience. 2022;25:104745 pubmed publisher |
Koklu A, Wustoni S, Guo K, Silva R, Salvigni L, Hama A, et al. Convection Driven Ultrarapid Protein Detection via Nanobody-Functionalized Organic Electrochemical Transistors. Adv Mater. 2022;34:e2202972 pubmed publisher |
Zimmerman O, Altman Doss A, Kaplonek P, Liang C, Vanblargan L, Chen R, et al. mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes. Cell Rep Med. 2022;3:100653 pubmed publisher |
Wang Q, Anang S, Iketani S, Guo Y, Liu L, Katsamba P, et al. Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529. Cell Rep. 2022;39:110924 pubmed publisher |
Wussow F, Kha M, Faircloth K, Nguyen V, Iniguez A, Martinez J, et al. COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants. iScience. 2022;25:104457 pubmed publisher |
Bixler S, Stefan C, Jay A, Rossi F, Ricks K, Shoemaker C, et al. Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model. Viruses. 2022;14: pubmed publisher |
Fu Y, Pan F, Zhao L, Zhao S, Yi J, Cai S. Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses. Int J Biol Macromol. 2022;207:715-729 pubmed publisher |
Lee Y, Grubbs G, Ramelli S, Levine A, Bathula A, Saharia K, et al. SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women. EBioMedicine. 2022;77:103940 pubmed publisher |
Uprichard S, O Brien A, Evdokimova M, Rowe C, Joyce C, Hackbart M, et al. Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals. Viruses. 2022;14: pubmed publisher |
Chiuppesi F, Nguyen V, Park Y, Contreras H, Karpinski V, Faircloth K, et al. Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates. NPJ Vaccines. 2022;7:7 pubmed publisher |
Qu J, Leirs K, Maes W, Imbrechts M, Callewaert N, Lagrou K, et al. Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood. ACS Sens. 2022;7:477-487 pubmed publisher |
Dutt T, LaVergne S, WEBB T, Baxter B, Stromberg S, McFann K, et al. Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease. J Immunol. 2022;208:685-696 pubmed publisher |
Lin W, Chen I, Chen H, Lee Y, Wu S. Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants. Front Immunol. 2021;12:795741 pubmed publisher |
Tang J, Grubbs G, Lee Y, Huang C, Ravichandran S, Forgacs D, et al. Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex. EBioMedicine. 2021;74:103748 pubmed publisher |
Song J, Chow R, Pena Hernandez M, Zhang L, Loeb S, So E, et al. LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans. bioRxiv. 2021;: pubmed publisher |
Caohuy H, Eidelman O, Chen T, Liu S, Yang Q, Bera A, et al. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells. Sci Rep. 2021;11:22195 pubmed publisher |
Yue S, Li Z, Lin Y, Yang Y, Yuan M, Pan Z, et al. Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody. Front Immunol. 2021;12:751584 pubmed publisher |
Maghsood F, Hassani D, Salimi V, Kardar G, Khoshnoodi J, Ghaderi A, et al. Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients. Viral Immunol. 2021;34:708-713 pubmed publisher |
Egorov A, Griffin S, Fuzawa M, Kobylanski J, Grindstaff R, Padgett W, et al. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail. Microbiol Spectr. 2021;9:e0069321 pubmed publisher |
Wu K, Chugh V, D Krishna V, Di Girolamo A, Wang Y, Saha R, et al. One-Step, Wash-free, Nanoparticle Clustering-Based Magnetic Particle Spectroscopy Bioassay Method for Detection of SARS-CoV-2 Spike and Nucleocapsid Proteins in the Liquid Phase. ACS Appl Mater Interfaces. 2021;13:44136-44146 pubmed publisher |
Wouters E, Verbrugghe C, Devloo R, Debruyne I, De Clippel D, Van Heddegem L, et al. A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma. Transfusion. 2021;61:2981-2990 pubmed publisher |
Tang J, Lee Y, Ravichandran S, Grubbs G, Huang C, Stauft C, et al. Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern. iScience. 2021;24:103006 pubmed publisher |
Cecon E, Burridge M, Cao L, Carter L, Ravichandran R, Dam J, et al. SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET. Cell Chem Biol. 2021;: pubmed publisher |
Garrido C, Hurst J, Lorang C, Aquino J, Rodriguez J, Pfeiffer T, et al. Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents. JCI Insight. 2021;6: pubmed publisher |
Schasfoort R, van Weperen J, van Amsterdam M, Parisot J, Hendriks J, Koerselman M, et al. High throughput surface plasmon resonance imaging method for clinical detection of presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection. MethodsX. 2021;8:101432 pubmed publisher |
Garrido C, Curtis A, Dennis M, Pathak S, Gao H, Montefiori D, et al. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Sci Immunol. 2021;6: pubmed publisher |
Guo K, Wustoni S, Koklu A, D xed az Galicia E, Moser M, Hama A, et al. Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistors. Nat Biomed Eng. 2021;5:666-677 pubmed publisher |
Luo S, Zhang P, Liu B, Yang C, Liang C, Wang Q, et al. Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates. Emerg Microbes Infect. 2021;10:1002-1015 pubmed publisher |
Bojadzic D, Alcazar O, Chen J, Chuang S, Condor Capcha J, Shehadeh L, et al. Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2. ACS Infect Dis. 2021;7:1519-1534 pubmed publisher |
Golden J, Zeng X, Cline C, Garrison A, White L, Fitzpatrick C, et al. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease. J Gen Virol. 2021;102: pubmed publisher |
Bertoglio F, Meier D, Langreder N, Steinke S, Rand U, Simonelli L, et al. SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface. Nat Commun. 2021;12:1577 pubmed publisher |
Kim Y, Lee M, Lee S, Chung H, Kim K, Lee T, et al. Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library. Int J Mol Sci. 2021;22: pubmed publisher |
Pradenas E, Trinit xe9 B, Urrea V, Marfil S, xc1 vila Nieto C, Rodr xed guez de la Concepci xf3 n M, et al. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (N Y). 2021;2:313-320.e4 pubmed publisher |
Steinbuck M, Seenappa L, Jakubowski A, McNeil L, Haqq C, Demuth P. A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2. Sci Adv. 2021;7: pubmed publisher |
Bojadzic D, Alcazar O, Buchwald P. Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19. Front Pharmacol. 2020;11:600372 pubmed publisher |
Asandei A, Mereuta L, Schiopu I, Park J, Seo C, Park Y, et al. Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit. ACS Appl Mater Interfaces. 2020;12:55649-55658 pubmed publisher |
Mazzini L, Martinuzzi D, Hyseni I, Benincasa L, Molesti E, Casa E, et al. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples. J Immunol Methods. 2021;489:112937 pubmed publisher |
Liu T, Hsiung J, Zhao S, Kost J, Sreedhar D, Hanson C, et al. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng. 2020;4:1188-1196 pubmed publisher |
Chang A, Croix M, Kenney P, Baron S, Hicar M. Serum Responses of Children With Kawasaki Disease Against Severe Acute Respiratory Syndrome Coronavirus 2 Proteins. Pediatr Infect Dis J. 2020;39:e366-e367 pubmed publisher |
Sohn K, Lee S, Kim H, Cheon S, Jeong H, Lee J, et al. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis. J Korean Med Sci. 2020;35:e343 pubmed publisher |
McAndrews K, Dowlatshahi D, Dai J, Becker L, Hensel J, Snowden L, et al. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity. JCI Insight. 2020;5: pubmed publisher |
Wang Y, Wang L, Cao H, Liu C. SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen. J Med Virol. 2021;93:892-898 pubmed publisher |
Chiuppesi F, Salazar M, Contreras H, Nguyen V, Martinez J, Park S, et al. Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine. bioRxiv. 2020;: pubmed publisher |
Ravichandran S, Coyle E, Klenow L, Tang J, Grubbs G, Liu S, et al. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits. Sci Transl Med. 2020;12: pubmed publisher |
. Nutrients in wheat, flour, and bread. Nutr Rev. 1967;25:118-21 pubmed |
Ochiai K, Naito S. [Studies on the drug-resistance transfer of Enterobacteriaceae. 19. Transmission of the resistance from resistant bacteria in the feces of newborn infants to sensitive Shigella]. Igaku To Seibutsugaku. 1966;73:180-2 pubmed |
